140 related articles for article (PubMed ID: 22848369)
1. Concordance of gene expression and functional correlation patterns across the NCI-60 cell lines and the Cancer Genome Atlas glioblastoma samples.
Zeeberg BR; Kohn KW; Kahn A; Larionov V; Weinstein JN; Reinhold W; Pommier Y
PLoS One; 2012; 7(7):e40062. PubMed ID: 22848369
[TBL] [Abstract][Full Text] [Related]
2. Identification of Immune-Related Genes Contributing to the Development of Glioblastoma Using Weighted Gene Co-expression Network Analysis.
Kong Y; Feng ZC; Zhang YL; Liu XF; Ma Y; Zhao ZM; Huang B; Chen AJ; Zhang D; Thorsen F; Wang J; Yang N; Li XG
Front Immunol; 2020; 11():1281. PubMed ID: 32765489
[No Abstract] [Full Text] [Related]
3. Analysis of the cancer genome atlas (TCGA) database identifies an inverse relationship between interleukin-13 receptor α1 and α2 gene expression and poor prognosis and drug resistance in subjects with glioblastoma multiforme.
Han J; Puri RK
J Neurooncol; 2018 Feb; 136(3):463-474. PubMed ID: 29168083
[TBL] [Abstract][Full Text] [Related]
4. Integrating global gene expression and radiation survival parameters across the 60 cell lines of the National Cancer Institute Anticancer Drug Screen.
Amundson SA; Do KT; Vinikoor LC; Lee RA; Koch-Paiz CA; Ahn J; Reimers M; Chen Y; Scudiero DA; Weinstein JN; Trent JM; Bittner ML; Meltzer PS; Fornace AJ
Cancer Res; 2008 Jan; 68(2):415-24. PubMed ID: 18199535
[TBL] [Abstract][Full Text] [Related]
5. Expression signature of IFN/STAT1 signaling genes predicts poor survival outcome in glioblastoma multiforme in a subtype-specific manner.
Duarte CW; Willey CD; Zhi D; Cui X; Harris JJ; Vaughan LK; Mehta T; McCubrey RO; Khodarev NN; Weichselbaum RR; Gillespie GY
PLoS One; 2012; 7(1):e29653. PubMed ID: 22242177
[TBL] [Abstract][Full Text] [Related]
6. Construction of co-expression modules related to survival by WGCNA and identification of potential prognostic biomarkers in glioblastoma.
Zhou J; Guo H; Liu L; Hao S; Guo Z; Zhang F; Gao Y; Wang Z; Zhang W
J Cell Mol Med; 2021 Feb; 25(3):1633-1644. PubMed ID: 33449451
[TBL] [Abstract][Full Text] [Related]
7. Cross-platform comparison and visualisation of gene expression data using co-inertia analysis.
Culhane AC; Perrière G; Higgins DG
BMC Bioinformatics; 2003 Nov; 4():59. PubMed ID: 14633289
[TBL] [Abstract][Full Text] [Related]
8. STAT6 expression in glioblastoma promotes invasive growth.
Merk BC; Owens JL; Lopes MB; Silva CM; Hussaini IM
BMC Cancer; 2011 May; 11():184. PubMed ID: 21595984
[TBL] [Abstract][Full Text] [Related]
9. Identification of potential crucial genes and molecular mechanisms in glioblastoma multiforme by bioinformatics analysis.
Chen X; Pan Y; Yan M; Bao G; Sun X
Mol Med Rep; 2020 Aug; 22(2):859-869. PubMed ID: 32467990
[TBL] [Abstract][Full Text] [Related]
10. A human functional protein interaction network and its application to cancer data analysis.
Wu G; Feng X; Stein L
Genome Biol; 2010; 11(5):R53. PubMed ID: 20482850
[TBL] [Abstract][Full Text] [Related]
11. Dexamethasone-mediated oncogenicity in vitro and in an animal model of glioblastoma.
Luedi MM; Singh SK; Mosley JC; Hassan ISA; Hatami M; Gumin J; Andereggen L; Sulman EP; Lang FF; Stueber F; Fuller GN; Colen RR; Zinn PO
J Neurosurg; 2018 Dec; 129(6):1446-1455. PubMed ID: 29328002
[TBL] [Abstract][Full Text] [Related]
12. The NCI Transcriptional Pharmacodynamics Workbench: A Tool to Examine Dynamic Expression Profiling of Therapeutic Response in the NCI-60 Cell Line Panel.
Monks A; Zhao Y; Hose C; Hamed H; Krushkal J; Fang J; Sonkin D; Palmisano A; Polley EC; Fogli LK; Konaté MM; Miller SB; Simpson MA; Voth AR; Li MC; Harris E; Wu X; Connelly JW; Rapisarda A; Teicher BA; Simon R; Doroshow JH
Cancer Res; 2018 Dec; 78(24):6807-6817. PubMed ID: 30355619
[TBL] [Abstract][Full Text] [Related]
13. Cancer association study of aminoacyl-tRNA synthetase signaling network in glioblastoma.
Kim YW; Kwon C; Liu JL; Kim SH; Kim S
PLoS One; 2012; 7(8):e40960. PubMed ID: 22952576
[TBL] [Abstract][Full Text] [Related]
14. mRNA and microRNA expression profiles of the NCI-60 integrated with drug activities.
Liu H; D'Andrade P; Fulmer-Smentek S; Lorenzi P; Kohn KW; Weinstein JN; Pommier Y; Reinhold WC
Mol Cancer Ther; 2010 May; 9(5):1080-91. PubMed ID: 20442302
[TBL] [Abstract][Full Text] [Related]
15. Bioinformatic analyses reveal a distinct Notch activation induced by STAT3 phosphorylation in the mesenchymal subtype of glioblastoma.
Cheng W; Zhang C; Ren X; Jiang Y; Han S; Liu Y; Cai J; Li M; Wang K; Liu Y; Hu H; Li Q; Yang P; Bao Z; Wu A
J Neurosurg; 2017 Jan; 126(1):249-259. PubMed ID: 26967788
[TBL] [Abstract][Full Text] [Related]
16. A three-microRNA signature identifies two subtypes of glioblastoma patients with different clinical outcomes.
Marziali G; Buccarelli M; Giuliani A; Ilari R; Grande S; Palma A; D'Alessandris QG; Martini M; Biffoni M; Pallini R; Ricci-Vitiani L
Mol Oncol; 2017 Sep; 11(9):1115-1129. PubMed ID: 28248456
[TBL] [Abstract][Full Text] [Related]
17. High expression of RFX4 is associated with tumor progression and poor prognosis in patients with glioblastoma.
Jeong HY; Kim HJ; Kim CE; Lee S; Choi MC; Kim SH
Int J Neurosci; 2021 Jan; 131(1):7-14. PubMed ID: 32075484
[No Abstract] [Full Text] [Related]
18. Prospective Series of Nine Long Noncoding RNAs Associated with Survival of Patients with Glioblastoma.
Lei B; Yu L; Jung TA; Deng Y; Xiang W; Liu Y; Qi S
J Neurol Surg A Cent Eur Neurosurg; 2018 Nov; 79(6):471-478. PubMed ID: 29959764
[TBL] [Abstract][Full Text] [Related]
19. Genome-wide expression profiling of glioblastoma using a large combined cohort.
Tang J; He D; Yang P; He J; Zhang Y
Sci Rep; 2018 Oct; 8(1):15104. PubMed ID: 30305647
[TBL] [Abstract][Full Text] [Related]
20. A cancer tissue-specific FAM72 expression profile defines a novel glioblastoma multiform (GBM) gene-mutation signature.
Rahane CS; Kutzner A; Heese K
J Neurooncol; 2019 Jan; 141(1):57-70. PubMed ID: 30414097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
